-
Signature
-
/s/Lisa Stockard as Attorney-in-Fact
-
Stock symbol
-
EFX
-
Transactions as of
-
Feb 11, 2025
-
Transactions value $
-
-$2,376,073
-
Form type
-
4
-
Date filed
-
2/13/2025, 04:13 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
EFX |
Common Stock |
Award |
$0 |
+2.37K |
+6.14% |
$0.00 |
41K |
Feb 11, 2025 |
Direct |
F1 |
transaction |
EFX |
Common Stock |
Tax liability |
-$449K |
-1.78K |
-4.33% |
$253.00 |
39.3K |
Feb 11, 2025 |
Direct |
F1 |
transaction |
EFX |
Common Stock |
Options Exercise |
$2M |
+13.4K |
+34.05% |
$149.53 |
52.6K |
Feb 12, 2025 |
Direct |
F1, F2 |
transaction |
EFX |
Common Stock |
Options Exercise |
$768K |
+5.54K |
+10.54% |
$138.45 |
58.2K |
Feb 12, 2025 |
Direct |
F1, F2 |
transaction |
EFX |
Common Stock |
Sale |
-$4.69M |
-18.9K |
-32.51% |
$248.18 |
39.3K |
Feb 12, 2025 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
EFX |
Stock Option/Right to Buy |
Options Exercise |
$0 |
-5.54K |
-100% |
$0.00 |
0 |
Feb 12, 2025 |
Common Stock |
5.54K |
$138.45 |
Direct |
|
transaction |
EFX |
Stock Option/Right to Buy |
Options Exercise |
$0 |
-13.4K |
-100% |
$0.00 |
0 |
Feb 12, 2025 |
Common Stock |
13.4K |
$149.53 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: